Company Search:
Advanced Search
Sponsored Links
Medifron DBT Co Ltd Company Snapshot
Medifron DBT Co Ltd operates in the Computers, peripherals & software sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medifron DBT Co Ltd with three other computer and electronic stores in Asia: Kantone Holdings Limited of Hong Kong (2018 sales of 136.74 million Hong Kong Dollars [US$17.47 million] of which 84% was System Sales including Software Licensin), Innovative Technology Development Corp of Vietnam (404.05 billion Dong [US$17.41 million] ), and KidariStudio Inc (19.62 billion Korean Won [US$16.76 million] of which 95% was Media Contents).

Sales Analysis. Medifron DBT Co Ltd reported sales of 19.89 billion Korean Won (US$16.99 million) for the year ending December of 2018. This represents a decrease of 4.9% versus 2017, when the company's sales were 20.91 billion Korean Won. Contributing to the drop in overall sales was the 74.3% decline in Medicine Business, from 95.46 million Korean Won to 24.54 million Korean Won. There were also decreases in sales in It Business (down 4.6% to 19.87 billion Korean Won) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medifron DBT Co Ltd
  Stock Performance Chart for Medifron DBT Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 5,120.00
(Figures in Korean Won)
1 Week -1.9%   13 Weeks 14.7%  
4 Weeks 4.7%   52 Weeks -2.1%  
Medifron DBT Co Ltd Key Data:
  Ticker: 065650 Country: Korea (South)
  Exchanges: SEO Major Industry: Retailing
    Sub Industry: Computers, Peripherals & Software
  2018 Sales 19,889,603,789
(Year Ending Jan 2019).
Employees: 23
  Currency: Korean Won Market Cap: 150,728,258,560
  Fiscal Yr Ends: December Shares Outstanding: 29,439,113
  Share Type: Common Closely Held Shares: 1,896,853
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.